ATOSSA THERAPEUTICS, INC. (ATOS) › Shareholders' EquityATOSSA THERAPEUTICS, INC. (ATOS) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2009: $31.7K2010: -$851.9K2011: $1.56M2012: $5.18M2013: $10.60M2014: $9.50M2015: $3.74M2016: $3.10M2017: $6.94M2018: $8.81M2019: $13.16M2020: $27.17M2021: $138.14M2022: $117.96M2023: $91.02M2024: $71.48M2025: $39.35M$39.35M2009Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$39.35M-44.9%2024$71.48M-21.5%2023$91.02M-22.8%2022$117.96M-14.6%2021$138.14M+408.5%2020$27.17M+106.5%2019$13.16M+49.4%2018$8.81M+26.9%2017$6.94M+124.0%2016$3.10M-17.2%2015$3.74M-60.6%2014$9.50M-10.4%2013$10.60M+104.8%2012$5.18M+231.8%2011$1.56M+283.1%2010-$851.9K-2788.7%2009$31.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share